Effects of device-based and manual sensory acuity training on nonspecific chronic low back pain: a three-arm randomized controlled trial protocol Authors: Ayse Gurluk, Pınar Kaya Saribas, Gokhan Ozkocak, Devrim Tarakci, Elif Hocaoglu Published: 2026 ABSTRACT AbstractBackgroundNonspecific chronic low back pain (NCLBP) is a prevalent and disabling condition often associated with impaired sensory discrimination and altered cortical representation. Sensory acuity training (SAT) has emerged as a promising strategy to target these neurophysiological mechanisms; however, the comparative effectiveness of technology-based versus manual sensory acuity interventions remains unclear. This protocol comprises a three-arm, randomized controlled trial designed to evaluate the effects of technology-based and manual SAT, in addition to conventional physiotherapy, compared with conventional physiotherapy alone, on pain and sensory discrimination performance in individuals with NCLBP.MethodsThis single-blind, three-arm parallel randomized controlled trial will recruit 66 adults with NCLBP (> 3 months). Participants will be randomly allocated (1:1:1) to the technology-based SAT, the manual SAT, or a control group. All participants will also receive 30 min of conventional physiotherapy, three times per week for 4 weeks. A blinded assessor will conduct evaluations at baseline, post-intervention, and follow-up. Primary outcomes include pain intensity measured by the visual analog scale, disability evaluated using the Roland-Morris Disability Questionnaire, manual two-point discrimination testing, and sensory acuity performance assessed through TactiPain parameters. Secondary outcomes include pressure pain threshold, joint position sense, laterality performance, central sensitization levels, fear of movement, pain catastrophizing, lumbar body awareness, and quality of life.DiscussionThis trial aims to provide high-quality evidence on whether technology-based SAT offers additional benefits compared with manual SAT or a control intervention. By addressing cortical- and sensory-based mechanisms underlying NCLBP, this study may inform the development of more targeted rehabilitation strategies, contribute to clinical decision-making, and guide future research on technology-assisted approaches in musculoskeletal pain rehabilitation.Trial registrationClinicalTrials.gov NCT07277803. Registered on December 2025.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13063-026-09804-2.Keywords: Nonspecific chronic low back pain, Sensory acuity training, Technology-based intervention, Central sensitization, Motor control exercise Introduction Background and rationale {9a} Nonspecific chronic low back pain (NCLBP) is one of the leading causes of disability worldwide, according to the World Health Organization (2023), affecting approximately 70% of the population at some point during their lifetime. Defined as pain persisting for at least 3 months and present for at least half of the past 6 months, this condition is characterized by recurrent or fluctuating pain throughout the day. Today, NCLBP is regarded not merely as a symptom but as a chronic and progressive condition arising from the interaction of multiple biopsychosocial etiological factors [1]. NCLBP constitutes a major global health problem due to its association with both physical disability and substantial economic burden, including treatment, rehabilitation, and loss of workforce productivity. In Türkiye, the lifetime prevalence of NCLBP ranges from 44 to 79%, with an annual prevalence of 35.99%, and it leads to significant productivity loss, particularly among the young population [2]. In 2019, it was reported that 568.4 million individuals worldwide required rehabilitation, yet this need remained largely unmet. In the USA, expenditures related to back and neck pain increased by 5.3% between 1996 and 2016, reaching 134.5 billion dollars, and represented the highest healthcare cost in 2016 [3]. Productivity losses also represent a substantial burden in chronic low back pain (CLBP); in the United States, the annual cost is approximately $1920 per person, while in Brazil, 79% of the total economic loss of $500 million has been attributed to reduced productivity [4]. The prolonged persistence of chronic pain leads to neuroplastic changes in the brain regions responsible for perceptual functioning, resulting in a reorganization of pain at the central nervous system (CNS) level [5]. Research has shown that in conditions such as NCLBP, phantom limb pain, and complex regional pain syndrome, the representations of the painful body regions in the S1 and S2 cortices become disorganized, leading to a diffuse and indistinct pain perception [6, 7]. Neurochemical and structural alterations in the somatosensory, motor, and cognitive domains have been reported in individuals with NCLBP, accompanied by reductions in body awareness, motor control, and tactile discrimination abilities [5]. These individuals exhibit pronounced sensory impairments, including increased two-point discrimination (2PD) thresholds [8], reduced graphesthesia accuracy, difficulties in tactile localization, and diminished vibration sense. Furthermore, the frequent occurrence of central sensitization (CS) leads to overtransmission of pain signals and hypersensitization and is directly related to the decrease in sensory acuity [9–11]. The complex etiology of NCLBP highlights the importance of neuroscience-based approaches in its treatment [5]. Within this context, manually delivered sensory acuity training (SAT) is a tactile localization-based method that relies on active attention and feedback, supports cortical reorganization, and contributes to improvements in pain and functional outcomes [12]. SAT has been shown to be effective in various chronic pain conditions such as phantom limb pain, complex regional pain syndrome, and NCLBP. It sharpens the representation of the sensory homunculus and reduces pain [13, 14]. While recent studies report sustained clinical benefits with SAT, high-quality randomized controlled trials are needed due to methodological variability. Current approaches assess not only tactile localization but also different dimensions of sensory acuity, such as orientation and temporal discrimination, allowing for the development of targeted sensorimotor retraining protocols [15, 16]. Technological methods and devices are important not only for sensory acuity measurement purposes but also for their potential to support sensory training. In recent years, wearable systems that provide tactile feedback have gained attention, particularly those designed in the form of belts, vests, or backpacks containing vibration motors [17]. These systems enhance tactile awareness and sensory feedback by delivering vibratory stimuli to the trunk. Studies conducted in the field of post-amputation rehabilitation have shown that different combinations of vibration intensity and duration improve tactile perception. It has also been suggested that vibrotactile training initiated in the early period may limit maladaptive cortical plasticity, preserve the accurate cortical representation of the limb, and reduce the development of phantom pain [18]. Accordingly, Stronks et al. (2017) reported that short-term computer-based sensory training applied to the lumbar region increased localization and intensity discrimination acuity by 36% and 44%, respectively, indicating that this approach offers a rapid and low-cost sensory training method [19]. Additionally, Barker et al. (2008) reported that the FairMed device they developed for individuals with CLBP provided reductions in pain and disability comparable to those achieved with TENS. However, they emphasized that this effect needs to be confirmed in larger samples due to the technical limitations of the device [20]. Explanation for the choice of comparators {9b} Sensorimotor-based and sensory feedback-oriented approaches, such as SAT and motor control exercises (MCE), have been reported to provide promising effects on pain and function in NCLBP [21]. This study consists of three research groups: the technology-based SAT group (T-SATG), the manual SAT group (M-SATG), and the control group (CG). Conventional physiotherapy that includes MCE will be applied to each of the research groups for comparison purposes. In addition, the T-SATG and M-SATG will receive a structured technological and manual SAT program, respectively, while the control group will receive a structured patient education (PE) program that does not provide additional sensory stimulation. In this way, the session durations will be equalized across all groups [3, 22]. Objectives {10} The primary aim of this study is to evaluate sensory acuity levels in individuals with NCLBP in a multidimensional manner and to determine the effects of a manually delivered and technology-based structured SAT program (combined with conventional physiotherapy) on pain intensity measured by the visual analog scale (VAS), lumbar 2PD thresholds, and the composite sensory acuity score (mean percentage accuracy of localization, orientation, and temporal discrimination). Accordingly, we hypothesize that integrating a structured sensory acuity training (SAT) program into conventional physiotherapy—particularly when delivered through technology-based methods—will lead to greater improvements in pain intensity, disability, sensory acuity performance, pressure pain threshold, joint position sense, pain catastrophizing, central sensitization, fear of movement, and quality of life (QoL) in individuals with NCLBP compared with manual SAT or conventional physiotherapy alone. With this newly structured SAT program, we propose an approach that trains different dimensions of sensory acuity in individuals with NCLBP, including localization (tactile stimulus location), orientation (direction of tactile stimuli), and temporal discrimination (intervals between tactile stimuli) through the enhancement of sensory profiles and the reorganization of the CNS. Methods: patient and public involvement, and trial design Patient and public involvement {11} Patients and the public were not involved in the design, conduct, or reporting of this study. This protocol was developed within an academic grant framework and within a fixed timeline; therefore, patient and public involvement was not feasible at the design stage. Participants will not be involved in study conduct; however, a plain-language summary of the study results will be made available to participants upon request following study completion. Trial design {12} This is a single-center, three-arm, parallel-group, assessor-blinded, superiority randomized controlled trial with 1:1:1 allocation. Methods: participants, interventions, and outcomes Trial setting {13} This study will be conducted at Medipol Acıbadem Regional Hospital in Istanbul, Türkiye. Participants with NCLBP will be screened for eligibility and referred by specialist physicians from the physical therapy and rehabilitation units, and only those meeting the predefined inclusion criteria will be enrolled. Characteristics of the people who are needed for the trial: CharacteristicThe people we would expect to see includedAgeAdults 25–45 years oldSexMale and female participants with NCLBPGenderGender identity will not be assessed; sex will be recorded as reported by participants/medical recordsRace, ethnicity and ancestryTurkish population; expected to consist predominantly of individuals of Turkish ethnicity, as the study is conducted in IstanbulSocioeconomic statusMixed socioeconomic status levels are expected; participants from outpatient musculoskeletal clinics typically include low-to-middle socioeconomic groups. Socioeconomic status is not used as an inclusion criterionGeographic locationRecruitment from Istanbul, Türkiye. Single-center hospital: Medipol Acıbadem Regional HospitalOther characteristics relevant to the trialChronic nonspecific low back pain > 3 months; CSI ≥ 40; PainDetect negative; no radiculopathy; no rheumatologic or systemic pain disorders; no surgery in last 3 years Eligibility criteria {14a} Inclusion criteria [23, 24]: Being between 25 and 45 years of age, with no spinal fracture or acute disc herniation. Being between 25 and 45 years of age, with no spinal fracture or acute disc herniation. Having pain complaints lasting longer than 3 months and a pain intensity score > 4/10 on a 10-cm VAS at screening. Having pain complaints lasting longer than 3 months and a pain intensity score > 4/10 on a 10-cm VAS at screening. Scoring 40 or above on the Central Sensitization Inventory. Scoring 40 or above on the Central Sensitization Inventory. Having no current psychiatric problems, cognitive impairments, or contraindications to exercise. Having no current psychiatric problems, cognitive impairments, or contraindications to exercise. Exclusion criteria [23–25]: i.Presence of severe spinal pathologies (e.g., lumbar stenosis, spondylolisthesis, tumors, infections, metastasis, osteoporotic fractures, significant structural deformities, inflammatory arthritis). Presence of severe spinal pathologies (e.g., lumbar stenosis, spondylolisthesis, tumors, infections, metastasis, osteoporotic fractures, significant structural deformities, inflammatory arthritis). ii.Conditions accompanied by radicular symptoms or neurological deficits (sciatica, nerve root compression). Conditions accompanied by radicular symptoms or neurological deficits (sciatica, nerve root compression). iii.Coexisting systemic or neurological diseases (diabetes mellitus, neuromuscular disorders, major central/peripheral nervous system disorders, epilepsy, psychiatric disorders). Coexisting systemic or neurological diseases (diabetes mellitus, neuromuscular disorders, major central/peripheral nervous system disorders, epilepsy, psychiatric disorders). iv.Pregnancy. Pregnancy. v.Lower extremity injuries. Lower extremity injuries. vi.History of spinal surgery within the past 3 years. History of spinal surgery within the past 3 years. vii.Chronic widespread pain syndromes (fibromyalgia, chronic fatigue syndrome). Chronic widespread pain syndromes (fibromyalgia, chronic fatigue syndrome). viii.Individuals receiving any additional treatment for NCLBP during the study period. Individuals receiving any additional treatment for NCLBP during the study period. Eligibility criteria for sites and those delivering interventions {14b} The study will be conducted at Medipol Acıbadem Regional Hospital in Istanbul, Türkiye. The hospital must have the following characteristics: A dedicated physiotherapy and rehabilitation unit. A dedicated physiotherapy and rehabilitation unit. Clinicians experienced in the treatment of NCLBP. Clinicians experienced in the treatment of NCLBP. Access to the necessary equipment for therapy and outcome measurements (algometer, esthesiometer, inclinometer, monofilament set, tablet computer, and vibrotactile device). Access to the necessary equipment for therapy and outcome measurements (algometer, esthesiometer, inclinometer, monofilament set, tablet computer, and vibrotactile device). Eligibility criteria for intervention providers: Interventions will be implemented by a single licensed physiotherapist who meets the following criteria: At least 3 years of clinical experience in musculoskeletal physiotherapy. At least 3 years of clinical experience in musculoskeletal physiotherapy. Ability to consistently deliver both manual sensory acuity training (SAT) and technology-assisted SAT procedures in accordance with the study protocol. Ability to consistently deliver both manual sensory acuity training (SAT) and technology-assisted SAT procedures in accordance with the study protocol. Who will take informed consent? {32a} The informed consent process will be conducted by physiotherapist researchers who are knowledgeable about the study design as well as the ethical and legal aspects of the study. Additional consent provisions for collection and use of participant data and biological specimens {32b} There is no planned ancillary study in which the data collected in this trial will be used. Participants will be informed that their de-identified data will be used solely for the purposes of the present study, and written consent will be obtained accordingly. Interventions and comparator Intervention and comparator description {15a} All participants with NCLBP will receive 30 min of conventional physiotherapy, 3 days per week for 4 weeks. To ensure consistent adherence to the study protocol and maintain participant safety, all participant enrollment and intervention procedures will be conducted under the supervision of the same physiotherapy team. Participants will be asked not to undergo any additional treatments for their lumbar region during the 4-week study period, and any changes in medication type or dosage will be recorded throughout the study. In this study, the MCE program included within conventional physiotherapy and applied to all participants will aim to achieve optimal control of the spine and pelvis through correct muscle activation, postural alignment, and movement integrity [26]. The program is based on a progressive system centered on the activation of the transversus abdominis and multifidus muscles [27]. The program will begin with basic exercises involving isolated contractions of these muscles [28] and will progress to more complex movements requiring co-activation, such as bridging and quadruped exercises [27]. In each session, the physiotherapist will guide participants and provide necessary corrections to ensure proper exercise technique [28]. The detailed and progressive 4-week MCE protocol is presented in Table 1. Table 1MCE protocolStageSets × repetitionsExercisesWeek 13 × 10Pelvic tilt, double-leg stance, bridge, cat–camel exerciseWeek 23 × 10Single-leg stance, single-leg bridge, cobra with arms lifted, trunk rotation in quadrupedal positionWeek 34 × 15Single-leg stance (eyes closed), unloaded trunk flexion and extension, straight leg raise, walking on a balance boardWeek 45 × 15Forward bending, weighted trunk flexion and extension on a balance board, step-up on a balance board, cross straight leg raise, eccentric squat MCE protocol Individuals with NCLBP included in the T-SATG and M-SATG will receive 30 min of SAT, three times per week for 4 weeks, with the difficulty gradually increasing. This training program consists of four sensory acuity dimensions applied sequentially: localization acuity training (LAT), orientation acuity training (OAT), temporal acuity training (TAT), and graphesthesia training (GT). LAT aims to improve the individual’s ability to perceive applied stimuli and accurately identify their locations [16, 29]. OAT focuses on enhancing the ability to distinguish the direction of two consecutive stimuli [16]. TAT targets the ability to correctly determine the number of stimuli when two stimuli with a temporal gap are delivered at a single point [15]. Finally, GT involves recognizing letters drawn on the skin and constitutes not only a tactile acuity task but also a complex process requiring cortical-level processing of sensory input and the formation of the letter image [9, 30]. During the training process, progression to the next training stage will occur when 80% accuracy is achieved for that week [29]. During the treatment, a 10-s response time will be allowed between each stimulus, with 1-min rest periods between sets within the training parameters and 2-min rest periods between training parameters. For both groups, participants will be asked to visually mark their responses related to the delivered stimuli within the training parameters (LAT, OAT, TAT, GT). Participants in the T-SAT group will mark their responses through a tablet application synchronized with the device (TactiPain). The system will automatically record correct and incorrect responses. Participants in the M-SAT group will be provided with a paper template indicating the areas representing the stimulus variables, and they will be asked to mark the corresponding stimulus variables they perceive on this template. All responses will be collected and recorded by the physiotherapist at the end of the session. This procedure will ensure standardization of the response process and maintain measurement reliability in both methods (Fig. 1). Visual stimuli used in sensory acuity training: a localization acuity task using a 16-hole grid, and b orientation acuity task using an eight-direction arrow The treatment procedures for all three groups will be delivered by the same experienced physiotherapist to ensure consistency across interventions and to minimize variability in treatment delivery. All intervention components have been reported in accordance with the Template for Intervention Description and Replication (TIDieR) checklist [31]. Technology-assisted sensory acuity training group (T-SATG) The TactiPain device is designed as a newly developed system aimed at improving sensory acuity levels in individuals with NCLBP. This device will deliver specific, defined, and controlled vibrotactile stimuli to the body during the training parameters. Participants will be asked to make decisions regarding these stimuli (e.g., localization, orientation, temporal discrimination, and graphesthesia). Immediate feedback on response accuracy will be provided. Previous studies have shown that applying vibrotactile stimuli with different durations and intensities can retrain sensory dysfunction and reduce pain after amputation [18, 32]. Similarly, it has been reported that short and automated sessions delivered with coin-type motors improve localization acuity and stimulus intensity discrimination [32]. It has been emphasized that high-quality randomized controlled studies on SAT are lacking, and existing protocols are heterogeneous [33]. Through TactiPain’s automated, standardized, and modifiable training system, treatment dosage will be controlled via vibrotactile stimuli delivered at different durations and intensities. This will provide an individualized and progressive training approach. The automatic randomization of variables such as stimulus location, direction, number, intensity, and duration, the visualization and recording of response accuracy on both the physiotherapist and participant interfaces, and the accurate identification of stimuli through strategic motor placement will enhance the uniqueness of the system. The TactiPain device (Fig. 2) will be designed as a wearable lumbar belt containing 16 vibration motors (Pololu – Shaftless Mini Vibration Motor, 10 × 3.4 mm) placed between the last rib and the sacrum. The motors will be aligned in a 4 × 4 matrix (47 mm horizontally and 43 mm vertically) according to distances recommended in the literature, and the combination of neoprene and cotton fabric will optimize both comfort and vibration transmission [34]. System overview and belt design of the device The device will operate in an integrated manner with a computer interface for the physiotherapist and a tablet application for the participant. Through the interface, the physiotherapist will be able to adjust the intensity of the vibration motors, the duration of each vibration, and the rest intervals between vibrations during the session. In contrast, the user interface will be simple and user-friendly, displaying only the recorded responses and response times. This innovative system, which provides a structured SAT protocol through vibration motors, aims to contribute scientifically to clinical decision-making processes by retraining sensory impairment mechanisms and reducing pain in individuals with NCLBP [14, 15, 20, 34–37]. During training, vibration intensity will be adjusted to correspond to different maximum motor voltage levels, specifically 40% (low), 60% (medium), and 80% (high). Vibration duration (500–200–100 ms) and interstimulus interval (1 s, 500 ms, 200 ms, 100 ms) will be progressively individualized from easier to more difficult based on participant performance (see Table 2). This structured progression aims to select the parameters most appropriate for the individual’s sensory perception profile and physiological responses, thereby optimizing sensory acuity skills. Perceptual sensitivity and response accuracy to stimuli delivered via vibration motors will serve as the primary progression criteria determining the continuity of training. This method is based on sensory training protocols recommended in the literature to enhance participants’ stimulus identification and discrimination abilities [20, 35–37]. Table 2Structured SAT protocolM-SATGT-SATGStageSensory acuity training (SAT)Prope typeStimulus durationIntensityVibration durationInterstimulus intervalWeek 1LAT, OAT, TATThick5 sHigh500 ms1 sWeek 2LAT, OAT, TATThick5 sMedium500 ms500 msWeek 3LAT, OAT, TAT, GTThin2 sMedium200 ms200 msWeek 4LAT, OAT, TAT, GTThin2 sLow100 ms100 ms Structured SAT protocol Manual sensory acuity training group (M-SATG) During this training, the thin and thick ends of a Semmes–Weinstein monofilament (model: #12–1659, size: 6.65, pressure: 300.0 g) will be used to vary stimulus intensity (pressure level) and to provide two different stimulus intensities in order to progressively increase difficulty [38]. The progression of pressure intensity and stimulus duration in the training will be structured as follows: In the first and second weeks of the intervention, tactile stimuli will be delivered using the thick end of the monofilament with a stimulus duration of 5 s. In the third and fourth weeks, training will progress by using the thin end of the monofilament with a stimulus duration of 2 s, thereby increasing the perceptual discrimination demand. A stopwatch will be used in each session to standardize stimulus duration. Detailed information regarding the protocol is presented in Table 2. All SAT parameters (localization, orientation, temporal acuity, and graphesthesia) will be applied using sets randomly generated before each training session via the random.org program. This method aims to prevent the development of habituation. All responses will be recorded by the researcher to monitor weekly progress. During the training, an adhesive grid template consisting of 16 holes will be placed between the participant’s last rib and sacrum, as shown in Fig. 1. This template was designed for application to the lumbar region based on previously reported two-point discrimination (2PD) thresholds. Wand et al. reported mean horizontal and vertical lumbar 2PD thresholds of approximately 46 mm and 43 mm, respectively. Before each session, a labeled adhesive grid template suitable for personal use will be prepared for each participant and this grid will be placed directly on the skin [34]. i.Localization acuity training (LAT) (Fig. 1): In the M-SAT group, tactile stimuli will be delivered over the 16 holes of the adhesive grid template placed on the lower back in a randomized sequence. In the T-SAT group, the same training protocol will be implemented through the device. The 16 vibration motors within the 4 × 4 matrix will be activated in a sequence determined by randomization [16, 29]. Localization acuity training (LAT) (Fig. 1): In the M-SAT group, tactile stimuli will be delivered over the 16 holes of the adhesive grid template placed on the lower back in a randomized sequence. In the T-SAT group, the same training protocol will be implemented through the device. The 16 vibration motors within the 4 × 4 matrix will be activated in a sequence determined by randomization [16, 29]. For both interventions, the participant will be asked to identify the perceived localization. Three sets will be administered in each session. Each set will be conducted according to a sequence of 20 randomly generated numbers determined by the researcher (e.g., 3, 5, 6, 7, 15, 1, 8, 14, 13, 9, 7, 11, 2, 10, 12, 4, 16, 2, 5, 8). ii.Orientation acuity training (OAT) (Fig. 1): In the M-SAT group, the physiotherapist will deliver tactile stimuli to the lumbar region using two consecutive touches in one of eight possible directions (right–left, up–down, upper right/upper left diagonal, lower right/lower left diagonal). In the T-SAT group, the same directions will be generated and presented to the participant through paired consecutive motor activations of the device. The participant will be asked to identify the perceived direction for both interventions. In both groups, the training will be administered in three randomized sets, each containing 20 directions [16, 39]. An example set: 1–2 (→), 9–13 (↓), 7–4 (↗), 11–12 (→), 10–5 (↖), 1–6 (↘), 10–9 (←), 15–1 (↑), 7–12 (↘), 8–7 (←), 5–2 (↗), 3–7 (↓), 16–1 (↖), 2–5 (↙), 6–2 (↑), 8–11 (↘), 2–6 (↓), 9–1 (→), 9–6 (↗), 5–1(↑). Orientation acuity training (OAT) (Fig. 1): In the M-SAT group, the physiotherapist will deliver tactile stimuli to the lumbar region using two consecutive touches in one of eight possible directions (right–left, up–down, upper right/upper left diagonal, lower right/lower left diagonal). In the T-SAT group, the same directions will be generated and presented to the participant through paired consecutive motor activations of the device. The participant will be asked to identify the perceived direction for both interventions. In both groups, the training will be administered in three randomized sets, each containing 20 directions [16, 39]. An example set: 1–2 (→), 9–13 (↓), 7–4 (↗), 11–12 (→), 10–5 (↖), 1–6 (↘), 10–9 (←), 15–1 (↑), 7–12 (↘), 8–7 (←), 5–2 (↗), 3–7 (↓), 16–1 (↖), 2–5 (↙), 6–2 (↑), 8–11 (↘), 2–6 (↓), 9–1 (→), 9–6 (↗), 5–1(↑). iii.Temporal acuity training (TAT): During this training, two reference points will be used: 5 cm to the right of the L3 vertebra and 5 cm to the left. For the M-SAT group, tactile stimuli will be delivered through only the 5th (right) or 8th (left) holes of the adhesive template at fixed intervals of 1 s, repeated 2, 3, 4, or 5 times. In the T-SAT group, the same task will be performed by sequential activation of only the 5th (right) or 8th (left) motors of the device. The motors will generate random sequences of 2–5 vibrations. These repeated stimulus counts will be presented randomly, and the participant will be asked to report the number of repetitions. The training will be administered in four sets in total—two for the right side and two for the left side—with each set consisting of 30 randomly generated repetitions [15, 29]. An example set: 3, 2, 5, 2, 4, 2, 3, 5, 4, 4, 3, 2, 5, 2, 3, 4, 5, 3, 4, 5. Temporal acuity training (TAT): During this training, two reference points will be used: 5 cm to the right of the L3 vertebra and 5 cm to the left. For the M-SAT group, tactile stimuli will be delivered through only the 5th (right) or 8th (left) holes of the adhesive template at fixed intervals of 1 s, repeated 2, 3, 4, or 5 times. In the T-SAT group, the same task will be performed by sequential activation of only the 5th (right) or 8th (left) motors of the device. The motors will generate random sequences of 2–5 vibrations. These repeated stimulus counts will be presented randomly, and the participant will be asked to report the number of repetitions. The training will be administered in four sets in total—two for the right side and two for the left side—with each set consisting of 30 randomly generated repetitions [15, 29]. An example set: 3, 2, 5, 2, 4, 2, 3, 5, 4, 4, 3, 2, 5, 2, 3, 4, 5, 3, 4, 5. iv.Graphesthesia training (GT): In the M-SAT group, the training will be applied to the bare lumbar region between the last rib and the sacrum without using any grid template. Random letters will be drawn in this area during GT training, which will begin in the 3rd week of the treatment program. In the third week, the letters will be applied in different sizes and directions, and in the fourth week, at different speeds (slow/normal/fast) [9, 30]. An example set for the third week is as follows: A, D, P, U, Y, F, Z, E, B, O, M, R, N, K, R, G, T, L, S, B. Graphesthesia training (GT): In the M-SAT group, the training will be applied to the bare lumbar region between the last rib and the sacrum without using any grid template. Random letters will be drawn in this area during GT training, which will begin in the 3rd week of the treatment program. In the third week, the letters will be applied in different sizes and directions, and in the fourth week, at different speeds (slow/normal/fast) [9, 30]. An example set for the third week is as follows: A, D, P, U, Y, F, Z, E, B, O, M, R, N, K, R, G, T, L, S, B. In the T-SAT group, the training will be carried out using the device’s 16-motor vibration matrix. Randomized shapes (–, |,/, +, square) and letters (C, F, H, L, M, N, T, U, V, Z) will be presented to the participant in the form of vibration sequences. The vibration patterns will be generated through sequential motor activation corresponding to the order in which the letter would be drawn. As the intensity of one motor decreases, the intensity of the next motor will increase to create a dynamic transition. For example, to represent the letter “U,” motors numbered 1–5–9–13–14–15–16–12-8–4 will be activated in sequence to form the intended vibration pathway. In both groups, the training will be administered in three randomized sets, each consisting of 20 letters [9, 15, 16, 29]. During all training tasks (LAT, OAT, TAT, GT), in the case of an incorrect response, the correct answer will be provided to participants, and after a few attempts, the same stimulus will be presented again. Control group (CG) Participants in the CG will receive a structured patient education (PE) program with a duration equal to that of the structured SAT programs applied in the other groups (30 min). This PE program is designed to improve safe movement, postural awareness, ergonomics, and self-management skills. Sessions will consist of interactive discussions lasting approximately 30 min at the end of each treatment session. In this way, session durations will be equalized with those of the T-SATG and M-SATG. Within the PE program, participants will be provided with basic information on spinal health and postural awareness. The importance of maintaining a neutral spine position during daily activities (sitting, standing, bending, lifting, etc.) will be emphasized, and the development of proper posture habits will be targeted [22, 40]. In addition, strategies related to movement and activity will be addressed to support the safe resumption of daily tasks, highlight the importance of staying active, and teach pacing approaches during symptom flare-ups. Recommendations will be provided on ergonomic principles such as workspace arrangement, appropriate lifting techniques, sitting posture, and strategies to reduce mechanical load on the lumbar region. Furthermore, the program will aim to enhance self-care awareness by encouraging regular physical activity, adequate rest, and healthy lifestyle habits. Participants will also be guided on recognizing their own limits, monitoring their symptoms, and seeking professional support when necessary, with education provided on red-flag symptoms [3, 22, 40]. We intentionally used non-sensory, non-specific education to control for attention/time without directly targeting sensory discrimination. The detailed and progressive 4-week PE protocol is presented in Table 3. Table 3Structured patient education program (control group)WeekLearning objectiveEducational contentPractical applicationWeek 1To develop awareness of spinal health, neutral posture, and safe movementNeutral posture and spinal protection principles during daily movements (sitting, standing and bending)Posture correction exercises in front of a mirror or wall; discussion of “correct vs. incorrect posture” ex; basic relaxation practice (5 min)Week 2To improve symptom management, safe movement, and problem-solving skillsActivity–rest balance, flare-up management, and awareness of pain-triggering factorsDiscussion using daily life scenarios; problem-solving exercise with the prompt “I had difficulty moving today because …”; progressive muscle relaxation (5 min)Week 3Ergonomic awareness, self-care, and strategies for managing stress and low moodOffice/home ergonomics, lifting techniques, sleep-nutrition routines, strategies for managing stress and depression, and relaxation habitsBody-awareness exercise (“How does my body respond in stressful moments?”); relaxation breathing practiceWeek 4To develop self-management skillsRegular physical activity, nutrition, sleep hygiene, medication adherence, and red-flag awarenessCreating a self-management plan (goal–barrier–solution) Structured patient education program (control group) Criteria for discontinuing or modifying allocated intervention {15b} The criteria for discontinuation or modification of the allocated intervention are as follows: (1) withdrawal of consent or a request to discontinue participation in the intervention; (2) occurrence of serious adverse events or unexpected side effects related to the intervention; (3) adherence to the treatment protocol falling below 70% or inability to attend three consecutive sessions. Participants who discontinue or modify the allocated intervention will not receive further intervention as per protocol; however, they will be encouraged to complete all scheduled outcome assessments and will be included in the intention-to-treat analysis whenever outcome data are available. Participant safety is the priority of the study. Therefore, in necessary situations such as the occurrence of serious adverse events or unexpected side effects related to the intervention, the relevant specialist physician will be contacted, and medical support will be provided with careful consideration of participant safety. Strategies to improve adherence to interventions {15c} Study continuity will be supported by sending telephone calls, emails, and short message reminders to participants regarding their upcoming study appointments. All study data will be closely monitored, and interviews with participants will be conducted to identify any issues that may limit participation. Concomitant care permitted or prohibited during the trial {15d} Participants will be instructed not to initiate any new physiotherapy, manual therapy, or structured exercise programs for low back pain during the intervention period. Ancillary for post‐trial care {34} N/A; no provisions for post-trial care. Outcomes {16} Primary and secondary clinical and physical outcome measures will be administered at baseline, immediately after the 4th week of treatment, and at 6 months post-treatment. Pain intensity will be assessed using a 10-cm VAS, with anchors ranging from “no pain” to “worst pain imaginable.” Participants will be asked to indicate their average pain intensity over the past 7 days by placing a mark on the scale, with higher scores indicating greater pain intensity [41]. Two-point discrimination (2PD) will be assessed using the standard two-point discrimination test (2PDT) with a mechanical aesthesiometer (baseline 12–1480). After a brief familiarization, the measurement will begin at a distance of 20 mm; if the participant perceives a single point, the distance will be increased by 5 mm, and the distance at which two points are first distinguished will be recorded as the ascending threshold. Then, using this distance as the starting point, the distance will be decreased by 5 mm to obtain the descending threshold, defined as the distance at which the participant again perceives a single point. The final 2PD value will be recorded as the average of two ascending and two descending thresholds obtained using the staircase (ascending–descending) method. Lower 2PD values indicate greater sensory acuity [42–45]. Sensory acuity will be objectively assessed using a standardized protocol to minimize assessor bias. A sensory acuity composite score will be calculated by summing the scores of localization, orientation, and temporal acuity accuracy (%) and then computing their mean, providing an overall index of sensory acuity. The thick end of the monofilament will be used during assessment to ensure consistent and clearly perceptible stimuli across participants and time points. Each task will be performed in two randomly ordered sets, with each set consisting of 20 repetitions that include variations in location, direction, and number of stimuli. Localization accuracy will be evaluated using a locognosia test, in which tactile stimuli are applied to a 4 × 4 grid numbered from 1 to 16, and participants indicate the perceived point on the template, with accuracy expressed as a percentage of correct responses. A similar version of this method has shown good (ICC 2.1 = 0.86) to excellent (ICC 2.1 = 0.92) intra-rater reliability in previous studies and has demonstrated construct validity through known-groups comparisons [46, 47]. Orientation accuracy will be assessed using a 4 × 4 grid numbered from 1 to 16. The percentage of correct responses indicating the direction of the second stimulus relative to the first—applied with a 1-s interval—will be calculated. For example, the monofilament will be applied to area 7 and then, 1 s later, to area 3. The participant will be expected to perceive these stimuli and indicate on the template that the direction from 7 to 3 corresponds to an upward vertical direction (↑) [39]. Temporal acuity accuracy will be assessed based on the percentage of correctly identified stimulus counts reported by the participant when tactile stimuli repeated 2, 3, 4, or 5 times are delivered at fixed 1-s intervals to a point located 5 cm to the right of the L3 vertebra. These reference locations correspond anatomically to the right and left points (holes 5 and 8) of the 16-point lumbar grid used during sensory acuity training, ensuring spatial consistency between training and outcome assessment locations. The number of stimuli (ranging from 2 to 5) will be randomized, and the same procedure will be repeated for the left side. For each lumbar region, one set consisting of 20 stimulus sequences will be administered, resulting in a total of two sets [43]. Disability levels will be assessed using the Roland-Morris Disability Questionnaire (RMDQ) [48], a 24-item yes/no scale evaluating disability related to low back pain. Total scores range from 0 to 24, with higher scores indicating greater disability. The scores above 14 reflect severe disability [49]. Secondary outcome measures: Body awareness and laterality perception levels will be assessed using the left–right judgment task (LRJT), calculated based on response time and accuracy in identifying the orientation of trunk images in the Recognise Online™ program [50]. Joint position sense (JPS) will be assessed using a valid and reliable inclinometer (Dualer IQ—Midvale, UT, USA). For each direction of movement (lumbar flexion and right-left lateral flexion), 50% of the achieved full range of motion (ROM) will be defined as the target position for JPS assessment. The researcher will guide the participant from the neutral position to the target position. The participant will be asked to maintain this position for 5 s and memorize it. Then, after returning to the starting position, the participant will be asked to actively reproduce the target position. When the participant believes they have reached the target, they will say “yes,” and the difference in degrees between the actual target and the reproduced position will be recorded as the JPS error. Each test will be repeated three times, and the average of these repetitions will be used in the analyses [51]. QoL will be assessed using the Short Form-36 (SF-36) Turkish version [52], a widely used generic health questionnaire in individuals with low back pain that evaluates health-related QoL across eight domains (physical functioning, bodily pain, role limitations due to physical problems, role limitations due to emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perception) using 36 items. Each domain is scored on a 0–100 scale, with higher scores indicating better QoL [52]. Pain pressure threshold (PPT) will be assessed using a digital algometer (Baseline® Dolorimeter – 22 lb capacity) [53]. Measurements will be performed in the prone position and bilaterally on the paraspinal muscles (longissimus dorsi and erector spinae) at the L4–L5 intervertebral space [54]. Prior to data collection, participants will undergo a practice trial by applying pressure to the biceps femoris muscle. A controlled clinical environment (24 °C) and the same time of day will be maintained throughout the test. Pressure will be applied at a constant rate of 10 N per second until the participant indicates the first sensation of pain by saying “stop,” and the value displayed on the algometer at this point will be recorded. Three trials will be performed for each region at 10-s intervals, and the average value will be used for analysis [55]. Central sensitization levels using the Central Sensitization Inventory (CSI) Turkish version [56] will be assessed with a 25-item, 5-point Likert-scale questionnaire, yielding total scores ranging from 0 to 100. Higher scores indicate greater symptom severity, and scores ≥ 40 reflect clinically relevant central sensitization. Fear of movement using the Tampa Kinesiophobia Scale (TKS) Turkish version will be assessed with a 17-item, 4-point Likert-scale questionnaire, yielding total scores ranging from 17 to 68. Higher scores indicate greater kinesiophobia, and scores ≥ 37 reflect clinically relevant kinesiophobia [57]. Pain catastrophizing levels using the Pain Catastrophizing Scale (PCS) Turkish version will be assessed with a 13-item Likert-scale questionnaire, with total scores ranging from 0 to 52; higher scores indicate greater pain catastrophizing [58]. Lumbar region body awareness levels using the Fremantle Back Awareness Questionnaire (FBAQ) Turkish version will be assessed with a 9-item Likert-scale questionnaire, scored on a 0–4 scale, yielding total scores ranging from 0 to 36. Higher scores indicate lower lumbar body awareness [59]. Harms {17} Adverse events, including any complications related to the intervention or arising within this population, will be monitored and documented throughout the entire duration of the study. Harms will be assessed both systematically and non-systematically to ensure comprehensive reporting. Systematically, at the beginning of each training session, participants will be asked whether they have experienced any new or worsening symptoms. In addition, the study team will directly observe participants during the sessions to monitor for signs of discomfort, physical strain, or any adverse response to the intervention. Non-systematically, participants will be encouraged to voluntarily report any problems or concerns they experience at any time during the study via telephone, text message, and/or email. Regardless of whether adverse events are identified through researcher inquiry or spontaneously reported by participants, all events will be reviewed by the clinical team and recorded in an Excel-based data registration system in accordance with institutional and regulatory requirements. Serious adverse events will be reported to the physical therapy physician and the principal investigator. Adverse events will be described primarily based on participant-reported symptoms and clinical judgment. Participant timeline {18} The participant timeline, including enrollment, interventions, and outcome assessments, is presented in Table 4 in accordance with the SPIRIT 2025 guidelines. Table 4Schedule of enrollment, intervention, assessment and follow-upVAS visual analog scale, 2PDT two-point discrimination test, LRJT left–right judgment task, JPS joint position sense, RMDQ Roland-Morris Disability Questionnaire, SF-36 Short Form-36, PPT pain pressure threshold, CSI Central Sensitization Inventory, TKS Tampa Kinesiophobia Scale, PCS Pain Catastrophizing Scale, FBAQ Fremantle Back Awareness Questionnaire, T-SATG technology-based sensory acuity training, M-SATG manual sensory acuity training, CG control group Schedule of enrollment, intervention, assessment and follow-up VAS visual analog scale, 2PDT two-point discrimination test, LRJT left–right judgment task, JPS joint position sense, RMDQ Roland-Morris Disability Questionnaire, SF-36 Short Form-36, PPT pain pressure threshold, CSI Central Sensitization Inventory, TKS Tampa Kinesiophobia Scale, PCS Pain Catastrophizing Scale, FBAQ Fremantle Back Awareness Questionnaire, T-SATG technology-based sensory acuity training, M-SATG manual sensory acuity training, CG control group Sample size {19} The required sample size was calculated to ensure adequate statistical power to detect differences in the primary outcome across the three study groups. The analysis will be performed using G*Power 3.1.9.4 based on a one-way ANOVA model. Assuming a large effect size (f = 0.40) in accordance with Cohen’s guidelines (1988) [60] and setting the significance level at α = 0.05, a total of 66 participants (22 per group) would provide approximately 81.8% power (1–β). Recruitment {20} Participants will be recruited from individuals who present to the Physical Therapy and Rehabilitation outpatient clinic at Istanbul Medipol Acıbadem Regional Hospital and are diagnosed with NCLBP by a specialist physician. In collaboration with physiotherapists and physical therapy specialists working at the hospital, a brief introduction to the study will be given, and suitable patients will be referred. Potential participants, after responding to these announcements or contacting the researchers through healthcare professionals, will undergo a preliminary telephone screening conducted by a researcher. During this call, general information about the study will be provided and basic eligibility criteria will be assessed. Individuals deemed eligible will be invited to an initial face-to-face assessment session. In the first session, written informed consent will be obtained and the official eligibility assessment will be conducted. Baseline outcome measurements will also be recorded during this session. After this stage, participants will be randomly assigned to one of the study groups. VAS visual analog scale, 2PDT two-point discrimination test, LRJT left–right judgment task, JPS joint position sense, RMDQ Roland-Morris Disability Questionnaire, SF-36 Short Form-36, PPT pain pressure threshold, CSI Central Sensitization Inventory, TKS Tampa Kinesiophobia Scale, PCS Pain Catastrophizing Scale, FBAQ Fremantle Back Awareness Questionnaire, T-SATG technology-based sensory acuity training, M-SATG manual sensory acuity training, CG control group. Assignment of interventions: randomization Sequence generation: who will generate the sequence {21a} The randomization sequence will be generated in advance by a member of the research team not involved in participant recruitment or outcome assessment. Sequence generation: type of randomization {21b} Given the known impact of central sensitization on pain-related outcomes and treatment response, stratified permuted block randomization based on baseline Central Sensitization Inventory (CSI) scores will be used to minimize potential imbalances between groups. Within each stratum, participants will be allocated (1:1:1) using permuted block randomization with randomly varying block sizes to reduce predictability. Randomization lists will be generated using a centralized, computer-based randomization system (e.g., studyrandomizer.com). Baseline CSI scores will be included as covariates in the primary statistical analyses. Allocation concealment mechanism {22} Allocation concealment will be ensured through the use of a centralized, computer-based randomization system, which reveals group assignment only after participant registration, thereby preventing foreknowledge of treatment allocation. Implementation {23} Eligible participants will be enrolled by the research staff. After enrollment, group assignment will be obtained via the centralized randomization system. Assignment of interventions: blinding Who will be blinded? {24a} The study is designed as single-blind; only the clinical assessor will be blinded to group allocation. Participants and therapists delivering the interventions will not be blinded due to the nature of the intervention. How will blinding be achieved? {24b} Blinding will be maintained by ensuring that the outcome assessor has no involvement in participant recruitment, randomization, or intervention delivery. All assessments will be conducted in a separate room, and no information related to group allocation will be disclosed to the assessor. Participants will be instructed not to reveal details of their treatment sessions during evaluations. Procedure for unblinding if needed {24c} Unblinding is not routinely planned. However, if knowledge of group allocation is deemed necessary for participant safety, the principal investigator (PI) may disclose allocation to the outcome assessor on a case-by-case basis. Any instance of unblinding and the underlying reason will be fully documented. Data collection and management Plans for assessment and collection of outcomes {25a} Clinical assessments will be conducted by the blinded assessor at three time points: at baseline, within 1 week after completion of the treatment process (after the 12th session), and 6 months after the end of treatment. All outcome measurement data will be recorded electronically (Microsoft Excel) without the use of paper forms and will be securely stored by the research team in an encrypted file. Data confidentiality will be maintained, with access restricted to authorized researchers only. Plans to promote participant retention and complete follow-up {25b} To maximize participant retention and ensure complete follow-up, reminder messages will be delivered via telephone, email, and short message service (SMS) 1 day prior to each scheduled appointment. Participants will be encouraged to complete all outcome assessments at the predefined time points whenever possible. Reasons for discontinuation or modification of the allocated intervention and/or loss to follow-up will be systematically documented. Data management {26} All collected data will be stored and managed in accordance with institutional and ethical standards. Electronic data will be recorded in password-protected computers and encrypted digital folders accessible only to authorized study personnel at Istanbul Medipol University. Paper-based data (e.g., consent forms) will be kept in locked and secure archive cabinets within the Physiotherapy Department. To ensure confidentiality, each participant will be assigned a unique study identification number, which will be used for all data entry, storage, and statistical analyses. Personal identifiers and contact forms will be stored separately from research data. Weekly data-quality checks will be conducted by the study coordinator to identify missing or inconsistent entries. All electronic data will be backed up regularly on an institutional secure server. All study data will be anonymized prior to analysis. Data sets provided to the statistician will be fully de-identified and will not contain any information that could reveal group allocation or participant identity. Access to the data will be restricted to authorized members of the research team. Confidentiality {33} Authorized university hospital personnel and relevant health authorities may access participants’ medical records to verify the accuracy of the study and ensure compliance with regulations. These individuals are bound by professional confidentiality obligations. Medical records containing participants’ identifying information will be accessible only to authorized researchers working at Istanbul Medipol Acıbadem Regional Hospital and the Physiotherapy and Rehabilitation Department of Medipol University. All personal and medical data will be kept confidential, and data protection will be ensured in accordance with the applicable Personal Data Protection Law and relevant ethical guidelines. Statistical methods Statistical methods for primary and secondary outcomes {27a} All statistical analyses will be conducted using R (R Core Team, 2025) and IBM SPSS Statistics (version 28). Statistical significance will be set at p < 0.05. Descriptive statistics will be used to summarize baseline characteristics and outcome measures. Primary and secondary outcomes will be analyzed using linear mixed-effects models, with fixed effects for group (intervention arms), time (baseline, post-intervention, and follow-up), and the group × time interaction, and a random intercept for participants to account for within-subject correlations. Model assumptions will be assessed using visual inspection of residual plots and Q–Q plots. When appropriate, Shapiro–Wilk tests will be applied to evaluate the normality of residuals. When significant group × time interactions are observed, planned pairwise comparisons with appropriate adjustment for multiple testing will be performed. Effect sizes will be reported as standardized mean differences or model-based estimates, as appropriate, and interpreted according to Cohen’s criteria [60]. Who will be included in each analysis {27b} The primary analysis will follow the intention-to-treat (ITT) principle, including all randomized participants in the groups to which they were allocated, regardless of adherence to the intervention protocol. How missing data will be handled in the analysis {27c} Missing outcome data will be handled using linear mixed-effects models with maximum likelihood estimation, which allow inclusion of all available data under a missing-at-random assumption without the need for explicit data imputation. The extent and reasons for missing data will be reported descriptively. Sensitivity analyses using per-protocol and/or multiple imputation approaches will be conducted, if appropriate, to assess the robustness of the findings. The per-protocol analysis will include participants who attended 70% of intervention sessions and completed the post-intervention assessment. Methods for additional analyses (e.g., subgroup analyses) {27d} N/A; no methods for additional analyses. Interim analyses {28b} N/A; no interim analyses. Protocol and statistical analysis plan {5} The study will be made publicly available through clinical trial registries, and the results will be provided to participants upon request. The datasets analyzed during the present study, the statistical code, and the full protocol can be obtained from the corresponding author upon reasonable request. Oversight and monitoring Composition of the coordinating centre and trial steering committee {3d} This study is being conducted within the Istanbul Medipol Acıbadem Regional Hospital, and its day-to-day management will be carried out by a study coordination team consisting of a physical medicine and rehabilitation specialist, the principal investigator (PI), the study coordinator, and a statistics expert. The physical medicine and rehabilitation specialist is responsible for identifying individuals eligible for participation in the study. Additionally, during interim clinical evaluations conducted throughout the treatment process, the specialist has the authority to decide whether the participant should continue in the study. The principal investigator will meet weekly with the study coordinator to review participant enrollment, retention rates, protocol deviations, and data collection processes. The study coordinator will organize and oversee the operational procedures of the study and ensure necessary coordination by communicating with the principal investigator and the clinical team when needed. The principal investigator will regularly attend these team meetings every 2 weeks to provide additional oversight and strategic guidance regarding the progress of the study. Composition of the data monitoring committee, its role and reporting structure {28a} Given the low-risk nature of the intervention and the academic scope of the project, a formal independent Data Monitoring Committee (DMC) has not been established. Study oversight will be conducted by the project investigators. Project progress and safety-related information will be summarized and reported to the Scientific and Technological Research Council of Türkiye (TUBITAK) at 6-month intervals in accordance with project reporting requirements. The investigators are responsible for maintaining data integrity, ensuring participant safety, and complying with the approved protocol, and any serious adverse events or significant protocol deviations will be promptly reported to the ethics committee. Frequency and plans for auditing trial conduct {29} The Project Management Group meets twice a month to review the trial run. Protocol amendments {31} Any changes to the study protocol that may have a potential impact on the following elements will be submitted to the Istanbul Medipol University Clinical Research Ethics Committee for review: study design, eligibility criteria, study procedures, study conduct, and study objectives. Any modification that may influence potential risks or benefits for participants will be submitted for ethical review and will only be implemented after approval is obtained. Changes in the study team will also be reported to the Istanbul Medipol University Ethics Committee. Any changes to the protocol will be communicated to participants verbally and subject to renewed confirmation, where deemed appropriate. Dissemination policy {8} The results of this study may be used for presentations at national and international scientific and health-related conferences, as well as for publication in peer-reviewed scientific and medical journals. In cases where individual results are presented, participant identities will be kept confidential, and only study code numbers will be used instead of names or other identifying information. The data collected during the study will be analyzed and reported after the completion of the study. Any data that could compromise the blinding of clinical assessors will not be reported before the study is completed. All articles, abstracts, or posters containing the study results will be submitted for review by the principal investigator. The principal investigator will recommend any necessary modifications prior to publication. Findings will be disseminated through peer-reviewed publications and conference presentations. Discussion The complex and multidimensional mechanisms of NCLBP demonstrate that biomechanical approaches alone are insufficient. Therefore, sensorimotor-based approaches have gained increasing importance. Sensory acuity training (SAT), based on repetitive tactile stimuli, is described as an innovative method that aims to reduce pain and improve functional recovery by reorganizing cortical representation [5, 61]. This neuroscientific perspective emphasizes a sensorimotor-based training approach compared to traditional rehabilitation approaches. In this context, the present study was designed to investigate the theoretical rationale and methodological framework of a structured, multidimensional sensory acuity training protocol, grounded in sensorimotor-based principles, for individuals with NCLBP. To provide a theoretical rationale for sensory acuity-based interventions in NCLBP, it is essential to consider the neuroplastic mechanisms underlying persistent pain. Neuroplastic changes occurring in conditions such as NCLBP have been shown to cause disorganized somatosensory cortical representations and a generalized perception of pain [5–7]. This maladaptive cortical reorganization provides a mechanistic framework for interventions aimed at refining somatosensory representations. It has been suggested that the processes of carefully perceiving a given stimulus, evaluating the perceived location, and accurately expressing it can also support cortical restructuring (Flor et al., 1997). However, most applications in the literature have focused on sensory localization training [12, 14, 29, 62]. Our study addresses a multidimensional sensory intervention encompassing localization, orientation, temporal acuity, and graphesthesia, rather than a single sensory acuity dimension. At the same time, delivering multidimensional sensory training in a consistent, repeatable, and dose-controlled manner solely through manual and therapist-dependent practices can be challenging. Kalin et al. [14] supported the potential effectiveness of SAT but emphasized the need for standardized protocols due to differences in content and dosage. Daffada et al. and Bagg et al. [12, 21] reported that sensorimotor-based approaches can have positive effects on pain and function but stated that further research is needed for the generalizability of the findings. Walti et al. [29] reported that SAT significantly reduced pain in the short term within a multi-component treatment program; however, they stated that its clinical applicability was limited due to the need for an assistant and practical constraints. In this context, technology-supported sensory training approaches that support standard stimulus presentation, repeatability, and clinical applicability have emerged to overcome these challenges. To address this gap in the literature, the present study proposes a structured protocol integrating a multidimensional SAT program with motor control exercises. Previous studies on technology-assisted sensory acuity training indicate that wearable vibrotactile systems can enhance tactile discrimination through structured sensory stimulation [17], and that vibration-based interventions may contribute to preserving adaptive cortical representations when applied early in rehabilitation [18]. In addition, short-duration, computer-based sensory training applied to the lumbar region has been shown to yield substantial improvements in tactile localization and intensity discrimination [19, 35]. Device-based approaches such as the FairMed system have also demonstrated reductions in pain and disability in individuals with chronic low back pain, although prior work has emphasized the need for improved technical precision and standardized protocols [20]. In this context, the present protocol provides a structured, reproducible, and attention-driven sensory acuity training framework, which may serve as a methodological reference for future technology-supported sensory training studies. The direct relationship between decreased sensory acuity and pain intensity suggests that SAT can be used as a therapeutic approach in chronic pain [11]. Several studies have reported that sensory localization training and similar interventions lead to reduced pain intensity, increased sensory sensitivity, and improved functional capacity in various chronic pain conditions [9, 14, 20, 61–63]. These findings suggest that the effects of SAT occur not only at the peripheral level but also through central mechanisms. Therefore, this supports the view that cortical reorganization in the primary somatosensory cortex (S1) can be supported through cognitive engagement and sensory feedback [62]. Technology-assisted SAT can further facilitate these mechanisms by providing attention-requiring, precise, and repeatable sensory stimulation and can increase cognitive engagement in the training process. Furthermore, the literature reports that SAT and sensorimotor approaches improve not only pain intensity but also catastrophizing and kinesiophobia levels [12, 64]. This highlights the necessity of considering the interaction between psychosocial factors and somatosensory processes for a holistic treatment approach. Accordingly, in our planned study, beliefs about pain, catastrophic thinking, and kinesiophobia will be evaluated as secondary outcome measures; thus, the aim is to gain a clearer understanding of this interaction. NCLBP is associated with significant functional limitations and decreased QoL at both individual and psychosocial levels; therefore, disability and QoL, in addition to pain, are among the key outcome measures [65–67]. Although the literature reports that SAT may have positive effects on pain, movement control, and physical function, more randomized controlled trials are needed to confirm clinical significance [14]. Furthermore, it has been shown that the combined application of sensorimotor approaches with motor control exercises (MCE) can improve functional recovery and patient satisfaction [12]. Accordingly, our planned protocol aims to contribute to improvements in function and QoL, as well as pain, by using SAT and MCE together. This planned study aims to address key limitations in the existing literature, including small sample sizes, heterogeneous methodologies, and the lack of standardized protocols, by introducing a structured, technology-assisted sensory acuity training framework. The proposed protocol integrates cognitive engagement with controlled sensory feedback while preserving the core principles of SAT, enabling standardized, reproducible, and clinically applicable training. Future research should further examine dose-response relationships, long-term cortical changes, and subgroup-specific responses to optimize and individualize sensory-based interventions. In conclusion, this study represents a significant step towards the systematic and standardized testing of SAT in chronic pain management. Once the applicability and feasibility of the protocol are confirmed, its replication with long-term follow-ups in different age groups and chronic pain syndromes will fill a significant gap in the literature and contribute to the development of neuroscience-based rehabilitation approaches. This study has some limitations. Since blinding participants and therapists is not feasible in rehabilitation research, outcome evaluators were blinded to reduce potential bias. Intervention duration, participant motivation, and individual differences can affect the sustainability of the program. Furthermore, as this trial is conducted in a single center, the generalizability of the findings to broader clinical settings may be limited. Nevertheless, the protocol has been structured taking these limitations into account and is expected to provide reproducible and valuable data for clinical applications. Trial status Protocol version number: Version 1.0 Protocol date: 30 December 2025. Date recruitment began: 15 February 2026. Approximate date when recruitment will be completed: 15 December 2027. Supplementary Information Supplementary Material 1 Acknowledgements Not applicable. Abbreviations Chronic low back pain Nonspecific chronic low back pain Central sensitization Sensory acuity training Motor control exercises Visual analog scale Patient education Control group Manual sensory acuity training group Technology-based sensory acuity training group Localization acuity training Orientation acuity training Temporal acuity training Graphesthesia training Left–right judgment task Joint position sense Roland-Morris Disability Questionnaire Short Form-36 Central Sensitization Inventory Tampa Kinesiophobia Scale Pain Catastrophizing Scale Fremantle Back Awareness Questionnaire Two-point discrimination test Authors’ contributions {3a} AG and PKS conceived the study, contributed to the study design, and drafted the manuscript. DT contributed to the development of the intervention protocol and methodological framework. GO provided clinical expertise and contributed to the interpretation of the clinical relevance of the study. EH contributed to the engineering and technical design of the study, including the development of the technical framework and the integration of the technology-assisted intervention. All authors critically revised the manuscript and approved the final version. Funding {7a} This research is supported by the Scientific and Technological Research Council of Türkiye (TUBITAK) under the 1001 program, with the project number 225S070. The funding agency will not be involved in the study design; the collection, management, analysis, or interpretation of the data; the preparation of the report; or the decision to submit the manuscript for publication. Data availability {6} De-identified participant-level data (IPD) may be shared upon reasonable request to the corresponding author following ethics committee approval. Data will not be publicly available due to privacy restrictions. Declarations Ethics approval and consent to participate {30} The study protocol was reviewed and approved by the Istanbul Medipol University Clinical Research Ethics Committee (Approval No: E-10840098-202.3.02-3981; Decision No: 239). Written informed consent will be obtained from all participants prior to enrollment. The trial has been registered on ClinicalTrials.gov under the identifier NCT07277803. Consent for publication Not applicable—this study and its outcome reports do not contain, and will not contain, any identifiable images or personal or clinical information of participants. Competing interests {7b} The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement De-identified participant-level data (IPD) may be shared upon reasonable request to the corresponding author following ethics committee approval. Data will not be publicly available due to privacy restrictions.